Financial stocks move higher as investors realize changes in U.S. financial regulation are years away. Merck and Schering-Plough are crushed as a new study slams Vytorin, their anticholesterol drug. Stocks break even in March; the first quarter is a bummer.
Read More...
[Source: MSN Money Latest Articles]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment